Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
With a market cap of 902.17B, Eli Lilly(LLY) trades at $944.86. The stock has a price-to-earnings ratio of 41.59 and currently yields dividends of 65.3%.
During the trading session on 2026-04-02, Eli Lilly(LLY) shares reached a daily high of $976.68 and a low of $919.00. At a current price of $944.86, the stock is +2.8% higher than the low and still -3.3% under the high.
Trading volume for Eli Lilly(LLY) stock has reached 6.27M, versus its average volume of 3.25M.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,133.95 and a low of $623.78.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,133.95 and a low of $623.78.
LLY News
Shares in Danish drugmaking giant Novo Nordisk (NVO) — already down about 26% since the start of the year — are now facing even more pressure after American arc...
The spotlight has been on Eli Lilly (LLY +3.84%) in recent years as the pharma player constructed a very valuable portfolio: one focused on diabetes and weight...
Key Points It will compete directly with a similar product from rival Novo Nordisk. It remains to be seen which pill American users will prefer. 10 stocks we...
Analyst ratings
83%
of 35 ratingsMore LLY News
(RTTNews) - The U.S. Food and Drug Administration has given the green light to Foundayo, a new daily weight-loss pill from Eli Lilly and Company, which shakes t...
BofA analyst Jason Gerberry raised the firm’s price target on Eli Lilly (LLY) to $1,294 from $1,293 and keeps a Buy rating on the shares. Following Foundayo’s U...
Eli Lilly (LLY) CEO Dave Ricks said the company's newly approved GLP-1 pill, Foundayo, will help expand Lilly's reach in the global weight-loss market in part b...
• What’s the outlook for GCPR shares? FDA Approves Eli Lilly's Oral Weight Loss On Wednesday, the FDA approved Eli Lilly and Co.’s (NYSE:LLY) Foundayo (orforg...
Eli Lilly (LLY) opposes the White House’s push to codify “most favored nation” drug pricing into law, CEO Dave Ricks said in an interview with CNBC. Lilly is on...
Novo Nordisk (NVO 0.95%) was the leader in the weight-loss market several years ago, with the company's now-famous anti-obesity medicine, Wegovy, flying off the...
Key Points Eli Lilly opposes the White House's push to codify 'Most Favored Nations' drug pricing, Lilly CEO Dave Ricks said in an interview with CNBC. Lilly i...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.